These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34033889)

  • 41. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study.
    Vivo A; Fitzpatrick MA; Suda KJ; Jones MM; Perencevich EN; Rubin MA; Ramanathan S; Wilson GM; Evans ME; Evans CT
    BMC Infect Dis; 2022 May; 22(1):491. PubMed ID: 35610601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019.
    Kracalik I; Ham DC; McAllister G; Smith AR; Vowles M; Kauber K; Zambrano M; Rodriguez G; Garner K; Chorbi K; Cassidy PM; McBee S; Stoney RJ; Moser K; Villarino ME; Zazueta OE; Bhatnagar A; Sula E; Stanton RA; Brown AC; Halpin AL; Epstein L; Walters MS;
    Emerg Infect Dis; 2022 Jan; 28(1):51-61. PubMed ID: 34932447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa isolated from four medical centres in Iran.
    Khalili Y; Omidnia P; Goli HR; Zamanlou S; Babaie F; Zahedi Bialvaei A; Esmailkhani A
    Mol Biol Rep; 2022 Sep; 49(9):8281-8289. PubMed ID: 35657451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan.
    Huang YT; Chang SC; Lauderdale TL; Yang AJ; Wang JT
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):211-6. PubMed ID: 17521840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC(6')-Iae in Japan.
    Kitao T; Tada T; Tanaka M; Narahara K; Shimojima M; Shimada K; Miyoshi-Akiyama T; Kirikae T
    Int J Antimicrob Agents; 2012 Jun; 39(6):518-21. PubMed ID: 22483560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular Characterization of the First Emerged NDM-1-Producing
    Hong JS; Song W; Park MJ; Jeong S; Lee N; Jeong SH
    Microb Drug Resist; 2021 Aug; 27(8):1063-1070. PubMed ID: 33332204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology and virulence of VIM-4 metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from burn patients in eastern Algeria.
    Meradji S; Barguigua A; Bentakouk MC; Nayme K; Zerouali K; Mazouz D; Chettibi H; Timinouni M
    Burns; 2016 Jun; 42(4):906-18. PubMed ID: 27156788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology and characterisation of carbapenem-non-susceptible Pseudomonas aeruginosa in a large intensive care unit in Jakarta, Indonesia.
    Saharman YR; Pelegrin AC; Karuniawati A; Sedono R; Aditianingsih D; Goessens WHF; Klaassen CHW; van Belkum A; Mirande C; Verbrugh HA; Severin JA
    Int J Antimicrob Agents; 2019 Nov; 54(5):655-660. PubMed ID: 31398483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in Kunming.
    Fan X; Wu Y; Xiao M; Xu ZP; Kudinha T; Bazaj A; Kong F; Xu YC
    Sci Rep; 2016 May; 6():26522. PubMed ID: 27198004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation and characterisation of carbapenem-resistant Pseudomonas aeruginosa from hospital environments in tertiary care hospitals in Dhaka, Bangladesh.
    Saha K; Kabir ND; Islam MR; Amin MB; Hoque KI; Halder K; Saleh AA; Parvez MAK; Begum K; Alam MJ; Islam MA
    J Glob Antimicrob Resist; 2022 Sep; 30():31-37. PubMed ID: 35447383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. bla
    Aruhomukama D; Najjuka CF; Kajumbula H; Okee M; Mboowa G; Sserwadda I; Mayanja R; Joloba ML; Kateete DP
    BMC Infect Dis; 2019 Oct; 19(1):853. PubMed ID: 31619192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
    Karampatakis T; Antachopoulos C; Tsakris A; Roilides E
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1211-1220. PubMed ID: 29644540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Carbapenem resistance in Pseudomonas aeruginosa isolated from urine cultures: prevalence and risk factors].
    Álvarez-Otero J; Lamas-Ferreiro JL; González-González L; Rodríguez-Conde I; Fernández-Soneira MJ; Arca-Blanco A; Bermúdez-Sanjurjo JR; de la Fuente-Aguado J
    Rev Esp Quimioter; 2017 Jun; 30(3):183-194. PubMed ID: 28440605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran.
    Heidari R; Farajzadeh Sheikh A; Hashemzadeh M; Farshadzadeh Z; Salmanzadeh S; Saki M
    Mol Biol Rep; 2022 May; 49(5):3811-3822. PubMed ID: 35169997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-beta-lactamase in a hospital located in Rio de Janeiro, Brazil.
    Carvalho AP; Albano RM; de Oliveira DN; Cidade DA; Teixeira LM; Marques Ede A
    Microb Drug Resist; 2006; 12(2):103-8. PubMed ID: 16922625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
    McCracken MG; Adam HJ; Blondeau JM; Walkty AJ; Karlowsky JA; Hoban DJ; Zhanel GG; Mulvey MR;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv32-iv38. PubMed ID: 31505643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SPM-1-producing Pseudomonas aeruginosa: analysis of the ancestor relationship using multilocus sequence typing, pulsed-field gel electrophoresis, and automated ribotyping.
    Silva FM; Carmo MS; Silbert S; Gales AC
    Microb Drug Resist; 2011 Jun; 17(2):215-20. PubMed ID: 21332364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbapenem-resistant Pseudomonas aeruginosa outbreak in an intensive care unit of a teaching hospital.
    Gales AC; Torres PL; Vilarinho DS; Melo RS; Silva CF; Cereda RF
    Braz J Infect Dis; 2004 Aug; 8(4):267-71. PubMed ID: 15565256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.